Blog Archives

Nabil A Issa

Nabil Issa is a partner in the Middle East and Islamic Finance Group of King & Spalding, working from the Dubai and affiliated Riyadh offices. Prior to joining King & Spalding, Mr. Issa worked for leading law firms in Dubai and Riyadh and was also an adjunct professor of business law at the University of Sharjah’s College of Business and Management. Mr. Issa also completed secondments in Houston and Washington, D.C., with another international law firm prior to joining King & Spalding.

Mr. Issa’s experience includes work in the areas of banking and finance, Shari’ah-compliant funds, private equity, international investments, healthcare and energy industry transactions, and Islamic finance issues. He is particularly known for his development of innovative Shari’ah-compliant CMA funds and investment structures for real estate and private equity investments in Saudi Arabia and the UAE.

Following graduation from the University of Pennsylvania, Mr. Issa was awarded a Fulbright Fellowship to UAE University to study the effects of membership in the World Trade Organization on the financial laws of the United Arab Emirates. Mr. Issa is proficient in Arabic as well as being fluent in English.

Mr. Issa has been recognized in the 2006 and 2007 editions and is highly ranked in the 2008-2013 editions of Chambers Global: The World’s Leading Lawyers for Business for his work in both Saudi Arabia and the UAE, in addition to investment funds in the Middle East. In the 2011-2013 editions of Chambers Global, Mr. Issa is ranked in Band 1 for his work in Saudi Arabia and in Band 2 for his work on investment funds in the Middle East. Mr. Issa is also recommended as a leading lawyer in banking and financing matters in the Legal 500 Europe, Middle East & Africa and was named among the “Leading Lawyers ” by Islamic Finance News in all 15 categories. Moreover, Mr. Issa is included in the inaugural 2008 and 2010 editions of Euromoney’s “Guide to the World’s Leading Islamic Finance Lawyers” and 2010 edition of Euromoney’s “Guide to the World’s Leading Emerging Markets Lawyers”.

Mr. Issa received his J.D. from the University of Pennsylvania Law School and a Graduate Certificate in Islamic & Middle Eastern Law from the University of Pennsylvania. He received his undergraduate degree, magna cum laude, from the University of California at San Diego, where he was elected to Phi Beta Kappa.

Healthcare Law Practise:

King & Spalding represents healthcare companies involved in the delivery of healthcare and payment for healthcare services across all facets of the legal issues they face. We also have one of the broadest and deepest benches of lawyers, scientists and consultants specializing in the representation of pharmaceutical, biotechnology and medical technology companies. We help our clients alleviate risk, accomplish their strategic goals and succeed in litigation. As one of the largest healthcare practices in the country, we have received national acclaim for excellence in transactional, litigation and regulatory representation of clients across the spectrum of healthcare.

King & Spalding:

Celebrating more than 125 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 800 lawyers in 17 offices in the United States, Europe, the Middle East and Asia. The firm also represents hundreds of clients with new ventures and mid-sized companies in emerging industries.

Long-standing client relationships are one of the surest barometers of a law firm’s success in meeting its clients’ needs for legal services. King & Spalding lawyers pride themselves on developing continuing client relationships that are productive, professional and collegial. The firm is one of only 52 law firms that have been on the BTI Client Service A-Team for 12 consecutive years—representing only 8% of the law firms serving the Fortune 1000.

The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, its uncompromising commitment to quality and its dedication to understanding the business and culture of its clients.

...read more >>

Juan Carlos Pró-Rísquez

Juan Carlos Pró-Rísquez is a labour and employment lawyer and is head of the labour and employment department of our Latin American practice.

Dr. Pró-Rísquez became a partner in October 1999. Previously, he practised at two other international law firms for about ten years. He specializes in labour and employment law, specifically as applied in the oil and gas, service, pharmaceuticals, consumer goods, banking and insurance, technology, engineering and airline industries. He is also the Latin American head of our life sciences and healthcare practice.

He has a strong background negotiating and drafting individual employment contracts and labour settlements, as well as in distribution contracts, labour and employment planning, consultancy agreements and expatriate transfers. Dr. Pró-Rísquez has also been involved in litigation before labour and tax tribunals and proceedings before administrative authorities regarding labour and employment matters. In addition, he has advised on matters regulated by the Organic labour law, the Organic prevention law, and social security legislation. Dr. Pró-Rísquez has extensive experience negotiating collective bargaining agreements on behalf of employers.

Dr. Pro-Risquez has acted as lead counsel to numerous employers implementing codes of conduct and conducting ethics compliance investigations in Latin America as well as on employment litigation in Venezuela and on the coordination of expatriate litigation and the hiring and transferring of expatriates in Latin America. He has also represented multinationals in occupational health and safety claims and counselled them on tax planning for the effective use of employee stock options.

Healthcare Law Practice:

Our global life sciences and healthcare team advises a range of innovative pharmaceutical, medical device and biotechnology companies as well as investors in the sector. We provide cutting-edge advice on the full range of legal issues that arise in the sector, from regulatory and compliance strategy through to patent litigation and corporate transactions.

In a period of global uncertainty, the sector faces a raft of legal and commercial hurdles that can affect the ability of many companies to do business in the industry. From the consequences of the patent cliff through to increased scrutiny by local regulatory authorities worldwide, our experienced lawyers effectively guide the world’s leading life sciences and healthcare corporations in navigating this difficult landscape.

Our healthcare team acts for numerous clients in the healthcare sector, including hospitals and health systems, academic medical centres, retail pharmacies and wholesale distributors, physician groups and health insurers.

We handle both domestic and cross-border matters throughout Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia, offering an integrated service to our life sciences and healthcare clients across the globe.

Norton Rose Fulbright:

We provide integrated domestic and international services to clients in Latin America and around the world. Since opening in 1997, our Caracas office has grown to be one of Venezuela’s largest and most-trusted legal practices. Our Bogotá office opened in 2010 and is already developing a leading reputation for energy and mining. Our presence in Rio de Janeiro, will allow us to advise our clients in Brazil on English, Canadian and US law issues. For Brazilian law issues, our team will work with a number of leading local law firms, with whom we have well established relations and a number of common clients. The focus of our practice will be on M&A in the oil & gas, energy, and infrastructure, mining and commodities sectors; projects and financing; aviation and shipping finance; restructuring; anti-bribery, corruption and investigations; and international arbitration and disputes.

With more than 80 lawyers based in Latin America who are entirely bilingual and multicultural in their legal training, we offer solid experience as well as strength and depth of resources in a wide range of industries, including energy and natural resources, mining, financial institutions, pharmaceuticals and technology. We are market leaders in our principal practice areas of dispute resolution, tax, corporate and commercial, banking, finance and insurance, real estate, employment and labour, intellectual property, private equity, competition administrative and public law.

...read more >>

Peter Edwards

Peter regularly advises health bodies on their reconfiguration plans and has supported a number of major consultation exercises as well as acting in several high-profile judicial review cases involving matters such as the closure of hospitals, fluoridation of the water supply and decisions not to fund particular medical treatments.

Peter’s employment law practice includes handling major organisational changes such as the establishment of the UK’s first Academic Health Science Centre and advising on TUPE transfers, redundancy consultation and pension issues.

Healthcare Law Practice:

Capsticks is a specialist health and social care law firm. We are ranked as the number one healthcare firm in both Legal 500 and Chambers legal directories and have offices in London, Birmingham, Leeds and Winchester.

In the NHS we act for national bodies including the Department of Health, the NHS Litigation Authority and NHS England. We represent organisations such as Barts and the London NHS Trust, Imperial College Healthcare NHS Trust, Birmingham Community Healthcare NHS Trust and Bradford Teaching Hospitals NHS Foundation Trust. We also act out for four out of the nine regulators of healthcare professionals in the UK, including the General Dental Council.

We also act for GPs in their role as primary care providers on a wide range of issues such a new surgery developments, leases with pharmacies, partnership deeds and declarations of trust, practice mergers and acquisitions, establishment of federations, premises funding queries, property litigation, employment law, mental capacity act issues and health and safety advice.

We advise a number of independent healthcare providers and we are very accustomed to navigating the territory between the private and public sector. Our private sector clients include major providers such as Nuffield Healthcare, HCA International, General Healthcare and Ramsay Healthcare, as well as healthcare charities Terrence Higgins Trust, Sue Ryder Care and the National AIDS Trust.

Capsticks Solicitors:

When we say we specialise in health and social care and social housing, we don’t mean half a dozen lawyers sitting in a corner of a big practice. We mean over 200 fee earners with a lot of experience, all committed to delivering excellent services to our clients. Many of them have been with us for quite a number (if not all) of our 30 years. When people join us they tend to stick around: partly because it’s a friendly place to work, but mostly because they find the work genuinely interesting. So when you talk to someone here, you can be sure they know what they’re talking about.

...read more >>

Alexey Trusov

Alexey Trusov practices in the areas of corporate, M&A and pharmaceutical and healthcare. He graduated from St. Petersburg State University’s School of Law in 1997 and received his LL.M. from Cleveland State University’s Cleveland-Marshall College of Law in 1998. He received his degree of Candidate of Science from St. Petersburg State University’s School of Law in 2002. He was admitted to the Russian bar in 1997, and currently serves as co-chair of the Association of International Pharmaceutical Manufacturers Legal Committee.

Mr. Trusov focuses his practice on general corporate, corporate restructuring, mergers and acquisitions, commercial law, pharmaceutical regulation, domestic securities and venture capital matters.

Healthcare Law Practice:

Health laws, regulations and interpretations change quickly and frequently — and sometimes dramatically. Understanding and mastering the nuances of this dynamic environment is a constant challenge. It is also absolutely essential if you want to stay in business, make a profit and stay out of trouble.

Billing practices. Quality of care. Surveys. Enforcement. Fraud and abuse. Reimbursement. Referral-source relations. Licensure and certification. Patient privacy. The list of issues and exposures goes on. And that’s before you get to the issues every business faces such as finance, M&A, joint ventures, benefits, labor and employment, taxes, litigation and technology.

You need sophisticated advisers — lawyers who understand the applicable laws, regulations and policies that govern your healthcare business. You also need practical advisers who know how these rules are applied and interpreted, and how they are likely to change.

At Baker & McKenzie, our Health Law practitioners have made it their business to know and understand the intricacies of the healthcare industry. We are steeped in the regulatory requirements and standards for compliance. And we bring a lawyerly business perspective to help you deal with strategic, legal and operational concerns.

The scope of our practice is broad. We serve the entire industry, from hospitals, LTCHs, nursing, independent and assisted living facilities to home health agencies, labs and medical groups, and from ESRD centers and rehab centers to continuing care retirement communities and hospices. We also serve pharmaceutical, biotech, medical device, DME suppliers and many other healthcare markets.

Baker & McKenzie:

Baker & McKenzie defined the global law firm in the 20th century, and we are redefining it to meet the challenges of the global economy in the 21st .

We bring to matters the instinctively global perspective and deep market knowledge and insights of more than 11,000 people in 77 offices worldwide. We have a distinctive global way of thinking, working and behaving – “fluency” – across borders, issues and practices.

We understand the challenges of the global economy because we have been at the forefront of its evolution. Since 1949, we have advised leading corporations on the issues of today’s integrated world market. We have cultivated the culture, commercial pragmatism and technical and interpersonal skills required to deliver world-class service tailored to the preferences of world-class clients worldwide.

Ours is a passionately collaborative community of 60 nationalities. We have the deep roots and knowledge of the language and culture of business required to address the nuances of local markets worldwide. And our culture of friendship and broad scope of practice enable us to navigate complexity across issues, practices and borders with ease.

...read more >>

Helga Bíró

Helga Bíró has significant experience in competition, consumer protection and commercial law matters. She co-heads the Firm’s Pharmaceutical and Healthcare practice in Budapest, and is a former counsel of the Ministry of Health. Ms. Bíró mainly handles regulatory matters relating to the pharmaceutical, food, cosmetics and medical device industries — both at the national and regional levels.

Ms. Bíró advises multinational pharmaceutical companies on legal issues relevant to clinical trials, licensing, product distribution as well as pricing and reimbursement. Clients in the medical device industry also rely on her for advice on the regulatory and licensing aspects of research, manufacturing, distribution and marketing of specific products and devices.

Healthcare Law Practice:

Health laws, regulations and interpretations change quickly and frequently — and sometimes dramatically. Understanding and mastering the nuances of this dynamic environment is a constant challenge. It is also absolutely essential if you want to stay in business, make a profit and stay out of trouble.

Billing practices. Quality of care. Surveys. Enforcement. Fraud and abuse. Reimbursement. Referral-source relations. Licensure and certification. Patient privacy. The list of issues and exposures goes on. And that’s before you get to the issues every business faces such as finance, M&A, joint ventures, benefits, labor and employment, taxes, litigation and technology.

You need sophisticated advisers — lawyers who understand the applicable laws, regulations and policies that govern your healthcare business. You also need practical advisers who know how these rules are applied and interpreted, and how they are likely to change.

At Baker & McKenzie, our Health Law practitioners have made it their business to know and understand the intricacies of the healthcare industry. We are steeped in the regulatory requirements and standards for compliance. And we bring a lawyerly business perspective to help you deal with strategic, legal and operational concerns.

The scope of our practice is broad. We serve the entire industry, from hospitals, LTCHs, nursing, independent and assisted living facilities to home health agencies, labs and medical groups, and from ESRD centers and rehab centers to continuing care retirement communities and hospices. We also serve pharmaceutical, biotech, medical device, DME suppliers and many other healthcare markets.

Baker & McKenzie:

Baker & McKenzie defined the global law firm in the 20th century, and we are redefining it to meet the challenges of the global economy in the 21st .

We bring to matters the instinctively global perspective and deep market knowledge and insights of more than 11,000 people in 77 offices worldwide. We have a distinctive global way of thinking, working and behaving – “fluency” – across borders, issues and practices.

We understand the challenges of the global economy because we have been at the forefront of its evolution. Since 1949, we have advised leading corporations on the issues of today’s integrated world market. We have cultivated the culture, commercial pragmatism and technical and interpersonal skills required to deliver world-class service tailored to the preferences of world-class clients worldwide.

Ours is a passionately collaborative community of 60 nationalities. We have the deep roots and knowledge of the language and culture of business required to address the nuances of local markets worldwide. And our culture of friendship and broad scope of practice enable us to navigate complexity across issues, practices and borders with ease.

...read more >>

Alan Zhou

Alan Zhou’s practice is focused in the areas of mergers & acquisitions, private equity/venture capital, regulatory compliance, and general corporate. Mr. Zhou has a particularly strong background in pharmaceutical and healthcare, and TMT industrial sectors.

Mr. Zhou has represented many multinational corporations, reputable Chinese state owned and private corporations, and private equity/venture capital funds. He has routinely represented such multinational corporations as Sanofi, Schlumberger, Siemens, Boehringer Ingelheim, Novartis, Aon, Bureau Veritas, Catalent, Terumo, Tosoh, Barclays, Societe Generale Bank, Samsung and SK Telecom. Mr. Zhou has not only worked for reputable Chinese private companies such as Focus Media, VIPShop, Acorn International, Hisoar Pharmaceutical, Tianyuan Biopharm, and GeneScience Pharma, he has also advised PRC state owned companies such as Shanghai Dasheng, Shanghai Industrial and Shanghai Airport Authority. In the area of PE/VC, Mr. Zhou has acted for CBRE Investors, Colony Capital, Navis Capital, Lightspeed Ventures, Qiming Ventures, DT Capital, NEA, New Alliance Capital, Warden International, WINS and other international and local PE/VC funds.

Mr. Zhou has been seconded as general counsel for China operations of Boehringer Ingelheim, a leading multinational pharmaceutical company, for more than nine years, and is responsible for various legal matters including general corporate, acquisitions and joint venture formation, compliance and regulatory, intellectual property and corporate restructuring.

Healthcare Law Practice:

Our Pharmaceutical and Healthcare (P&H) practice group is one of the leading advisers in China as this group not only has premium knowledge but also thorough understanding of the practice of P&H industry. We have provided ‘one-stop’ legal services for every area of the P&H industry, including drug R&D, clinical research organizations (CRO), pharmaceuticals, life sciences, biotechnology, medical devices, supply producers and distributors, hospitals and other healthcare providers, as well as various investment funds in the P&H sector.

Global advises clients on challenging P&H legal issues such as regulatory compliance, structuring transactions and contractual arrangements, realization of pipeline and geographic expansions, capital raising and project financing, mergers and acquisitions, reorganisations, IP protection, licensing and distribution arrangements, settlement of disputes involving adverse effects in clinical trials and medical treatment, etc.

Global also has close links to industrial associations and is involved in making recommendations on industry codes of conduct.

Global Law Office:

The history of Global Law Office dates back to 1984, when it became the first law firm in the People’s Republic of China (the “PRC”) to take an international perspective on its business, fully embracing the outside world.

In today’s global economy, we continue to set the pace as the PRC’s most innovative and progressive law firm. In doing so, we build on the energy and creativity of our highly qualified professionals, most of whom have gained qualifications and hands-on experience in law schools and firms throughout Asia, North America, Europe and Australia.

Our clients are the most important part of our business. We have attracted clients from all parts of the world, working in countless industries and market areas.

Our value is delivered to our international and domestic clients through our deep knowledge and experience across the full range of practice areas and industries affected by Chinese law. As one of the country’s most well-established and respected firms, we can bring our clients the legal and cultural understanding needed for long-term success in the PRC.

...read more >>

Paulina Kieszkowska-Knapik

Paulina Kieszkowska-Knapik, advocate, advises companies and industry organisations on healthcare law, especially the Pharmaceutical Law, the Reimbursement Act and the Act on Medical Activity.

Paulina Kieszkowska-Knapik is also a co-founder of the Lege Pharmaciae Foundation, a non-governmental organisation formed to analyse and hold a public debate on defects in legal regulations in the healthcare sector. Paulina Kieszkowska-Knapik works with the Civic Legislation Forum at the Stefan Batory Foundation on the introduction of European lawmaking standards in Poland.

Recommended for many years by Polish (Rzeczpospolita and Dziennik Gazeta Prawna) and international (Chambers Europe, PLC Which Lawyer) rankings as the best specialist in pharmaceutical law in Poland. She advises patient organisations pro bono, including the Polish Coalition of Cancer Patient Organisations, the Alivia Foundation and the Federation of
Polish Patients. Paulina worked at Baker & McKenzie law firm for a decade, having previously worked at CMS Cameron McKenna.

Kieszkowska Rutkowska Kolasiński:

The Kieszkowska Rutkowska Kolasiński law firm was established by recognised experts in pharmaceutical and medical law – Paulina Kieszkowska-Knapik, Advocate, Ewa Rutkowska, Advocate, and competition law – Marcin Kolasiński, Legal Advisor. The law firm comprises an experienced team, which has worked with the founders for a long time.

We all have many years of experience of working in international law firms (including Baker & McKenzie, Hogan Lovells and CMS Cameron McKenna).

We have been regularly recommended as leading lawyers in pharmaceutical law and competition law by Polish and international rankings of law firms and lawyers, such as Chambers Europe, Legal 500 and Rzeczpospolita. The Chambers Europe 2014 ranking acknowledged our law firm as the best Life Sciences practice in Poland.

...read more >>